STOCK TITAN

Kewaunee Scienti reported $282.0M in revenue and $9.6M in net income for fiscal 2026. See the full KEQU financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027

Kewaunee Scientific (NASDAQ: KEQU) announced it will release its first quarter fiscal year 2027 financial results on Wednesday, September 9, 2026, after the close of trading.

(Neutral)
Tags
earnings date

Kewaunee Scientific (NASDAQ: KEQU) announced it will release its first quarter fiscal year 2027 financial results on Wednesday, September 9, 2026, after the close of trading. According to Kewaunee Scientific, the results will be available on its website at www.kewaunee.com following the release.

The company, founded in 1906 and headquartered in Statesville, North Carolina, designs, manufactures, and installs laboratory, healthcare, and technical furniture, including casework, fume hoods, modular systems, healthcare storage, work surfaces, sinks, and biological safety cabinets. It operates manufacturing facilities in North Carolina, Minnesota, and Bangalore, plus warehouse and OEM partnerships in Europe and China.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – KEQU

+0.56%
+0.56% Session close to close

In the Aug 26 session, KEQU gained 0.56%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

STATESVILLE, N.C., Aug. 25, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its first quarter fiscal year 2027 financial results on Wednesday, September 9, 2026 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release.

Kewaunee Scientific Corporation (PRNewsFoto/Kewaunee Scientific Corporation)

About Kewaunee Scientific

Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's portfolio includes laboratory casework, fume hoods, adaptable modular systems, healthcare storage solutions, epoxy resin work surfaces and sinks, biological safety cabinets, and other critical containment lab furniture solutions.

The Company's corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, India, Saudi Arabia, Spain, and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. The Company also operates manufacturing facilities in Plymouth and Long Lake, Minnesota, and maintains warehouse partnerships in the Netherlands and OEM partnerships in China through its acquisition of Nu Aire, Inc., supporting customers around the world.

Learn more at http://www.kewaunee.com.

This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the Nu Aire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 30, 2026, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Donald T. Gardner III

704/871-3274

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kewaunee-scientific-to-report-results-for-first-quarter-fiscal-year-2027-302859810.html

SOURCE Kewaunee Scientific Corporation

FAQ

When will Kewaunee Scientific (NASDAQ: KEQU) report Q1 fiscal 2027 earnings?

Kewaunee Scientific plans to report its first quarter fiscal 2027 results on Wednesday, September 9, 2026, after the market close. According to Kewaunee Scientific, the financial information will be posted on the company’s website once released.

Where can investors find Kewaunee Scientific’s Q1 FY 2027 results for KEQU?

Investors can access Kewaunee Scientific’s Q1 fiscal 2027 results on the company’s website, www.kewaunee.com, after the release on September 9, 2026. According to Kewaunee Scientific, additional SEC filings are also available at www.sec.gov.

What does Kewaunee Scientific (KEQU) do as a business?

Kewaunee Scientific designs, manufactures, and installs laboratory, healthcare, and technical furniture products. According to Kewaunee Scientific, its portfolio includes lab casework, fume hoods, modular systems, healthcare storage, epoxy work surfaces and sinks, and biological safety cabinets for global customers.

Where are Kewaunee Scientific’s main operations and manufacturing facilities located?

Kewaunee Scientific is headquartered in Statesville, North Carolina, with sales offices in the U.S., India, Saudi Arabia, Spain, and Singapore. According to Kewaunee Scientific, it operates manufacturing in North Carolina, Minnesota, and Bangalore, plus warehouse and OEM partnerships in Europe and China.

What forward-looking risks does Kewaunee Scientific highlight for KEQU investors?

Kewaunee Scientific notes risks related to the Nu Aire acquisition benefits, economic conditions, supply disruptions, customer demand changes, and foreign currency. According to Kewaunee Scientific, additional risk factors appear in its Form 10-K for the year ended April 30, 2026.

How can investors contact Kewaunee Scientific investor relations about KEQU?

Investors can contact Donald T. Gardner III at phone number 704/871-3274 for additional information. According to Kewaunee Scientific, further investor materials are available on its website and through its SEC filings.